Clinical trial
An Open-label, Randomized, Two-period Crossover Study to Evaluate the Safety Use of the InsuPatch Device in Daily Life Conditions.
NCT01283425 is registered in ClinicalTrials.gov with Insuline Medical Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, Randomized, Two-period Crossover Study to Evaluate the Safety Use of the InsuPatch Device in Daily Life Conditions.
- Lead sponsor
- Insuline Medical Ltd.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2011
- Completion date
- April 30, 2012
- Enrollment
- 147 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.